glucagon has been researched along with erythromycin in 5 studies
Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (erythromycin) | Trials (erythromycin) | Recent Studies (post-2010) (erythromycin) |
---|---|---|---|---|---|
26,039 | 1,498 | 3,054 | 14,524 | 1,138 | 1,926 |
Protein | Taxonomy | glucagon (IC50) | erythromycin (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 1.156 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 1.045 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 1.156 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 1.156 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 1.156 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.039 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 1.156 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Roos, A; de Zwart, IM; Eilers, PH; Kunz, P; Lamb, HJ; Masclee, AA; Mearadji, B | 1 |
Boden, GH; Fisher, RS; Gonlachanvit, S; Hsu, CW; Knight, LC; Maurer, AH; Parkman, HP | 1 |
Allocca, M; Bianchi, PA; Cantù, P; Carmagnola, S; Penagini, R | 1 |
Holst, JJ; Kemmeries, G; Meier, JJ; Nauck, MA | 1 |
Cantù, P; Carmagnola, S; Penagini, R | 1 |
2 trial(s) available for glucagon and erythromycin
Article | Year |
---|---|
Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients.
Topics: Adult; Aged; Analgesics, Opioid; Anti-Bacterial Agents; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Glucagon; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Morphine; Placebo Effect; Postprandial Period; Radionuclide Imaging; Stomach | 2003 |
Mechanoreceptors of the proximal stomach: Role in triggering transient lower esophageal sphincter relaxation.
Topics: Adult; Blood Glucose; Erythromycin; Esophagogastric Junction; Female; Gastrointestinal Agents; Gastrointestinal Motility; Glucagon; Humans; Male; Mechanoreceptors; Muscle Relaxation; Pressure; Stomach | 2004 |
3 other study(ies) available for glucagon and erythromycin
Article | Year |
---|---|
Gastric motility: comparison of assessment with real-time MR imaging or barostat measurement initial experience.
Topics: Adult; Erythromycin; Fasting; Female; Gastrointestinal Agents; Gastrointestinal Motility; Glucagon; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pressure; Stomach | 2002 |
Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
Topics: Adult; Blood Glucose; C-Peptide; Cisapride; Domperidone; Eating; Erythromycin; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Infusions, Intravenous; Insulin; Male; Metoclopramide; Peptide Fragments; Placebos; Protein Precursors; Reference Values | 2005 |
Mechanoreceptors of the proximal stomach and perception of gastric distension.
Topics: Adult; Blood Glucose; Erythromycin; Female; Glucagon; Humans; Hunger; Male; Mechanoreceptors; Muscle Contraction; Muscle Relaxation; Perception; Pressure; Sensation; Stomach | 2005 |